Back to 
Woodline Partners LP
Woodline Partners LP
CORT
Showing 0 of 7 quarters
Position history for Woodline Partners LP's holdings in CORCEPT THERAPEUTICS INC
No. Woodline Partners exited its CORT (Corcept Therapeutics) position in Q1 2023. Its Q4 2022 13F listed 912,391 shares worth $18.5M. Woodline Partners first reported CORT in Q4 2020 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.